SCHEMBL563891

SCHEMBL563891

CC1(C)C[CH]CC(C)(C)N1O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289296 0.72
SCHEMBL588998 0.71 TSHR (0.30)
SCHEMBL3622381 0.71 GAA (0.32) GAAL3MBTL1
SCHEMBL244419 0.69 GAA (0.39) GAAL3MBTL1ALDH1A1
SCHEMBL11491618 0.69
SCHEMBL7760179 0.67 ESR1 (0.42) L3MBTL1
SCHEMBL320236 0.67 GAA (0.30) GAAL3MBTL1
SCHEMBL9122682 0.66
Hydrochloric Acid SCHEMBL4555681 0.66
SCHEMBL4329971 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820846-B1 COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER ECOLAB USA INC (US) 2024-01-03 EP claimed
US-20230312770-A1 ANTIFOULANT COMPOSITIONS FOR VAPOR-SPACE APPLICATIONS ECOLAB USA INC. (US) 2023-10-05 US claimed
US-20230312440-A1 ANTIFOULANT COMPOSITIONS FOR HIGH-SEVERITY PROCESSING OF VINYLIC MONOMER STREAMS ECOLAB USA INC. (US) 2023-10-05 US claimed
WO-2023192843-A1 ANTIFOULANT COMPOSITIONS FOR HIGH-SEVERITY PROCESSING OF VINYLIC MONOMER STREAMS ECOLAB USA INC. (US) 2023-10-05 WO claimed
WO-2023192868-A1 INHIBITOR OF VAPOR SPACE POLYMERIZATION ECOLAB USA INC. (US) 2023-10-05 WO claimed
WO-2023192847-A1 ANTIFOULANT COMPOSITIONS FOR VAPOR-SPACE APPLICATIONS ECOLAB USA INC. (US) 2023-10-05 WO claimed
WO-2023192866-A1 ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS ECOLAB USA INC. (US) 2023-10-05 WO claimed
US-20230312441-A1 ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS ECOLAB USA INC. (US) 2023-10-05 US claimed
US-20230312477-A1 INHIBITOR OF VAPOR SPACE POLYMERIZATION ECOLAB USA INC. (US) 2023-10-05 US claimed
US-20220119365-A1 CB1R RECEPTOR BLOCKERS WITH ACYCLIC BACKBONES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2022-04-21 US claimed
EP-1395545-A1 METHODS AND COMPOSITIONS FOR INHIBITING POLYMERIZATION OF VINYL MONOMERS GE Betz, Inc. (US) 2004-03-10 EP claimed
EP-0912471-B1 POLYMERISATION INHIBITOR MARKS A H & CO LTD (GB) 2003-08-27 EP claimed
WO-2002094763-A1 METHODS AND COMPOSITIONS FOR INHIBITING POLYMERIZATION OF VINYL MONOMERS GE BETZ, INC. (US) 2002-11-28 WO claimed
US-6409887-B1 FOR INHIBITING OLEFINIC POLYMERISATION AAH MARKS AND COMPANY LIMITED (GB) 2002-06-25 US claimed
CN-1251841-A Free radical polymerization in presence of plurality of stable free radicals ATOCHEM ELF SA (FR) 2000-05-03 CN claimed
EP-0822835-A1 HYBRID MAGNETIC RESONANCE CONTRAST AGENTS IMARX PHARMACEUTICAL CORP. (US) 1998-02-11 EP claimed
US-5714612-A LIGHT STABILIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-03 US claimed
WO-1996032967-A1 HYBRID MAGNETIC RESONANCE CONTRAST AGENTS IMARX PHARMACEUTICAL CORPORATION (US) 1996-10-24 WO claimed
US-5506286-A BLENDING STABILZER WITH SYNTHETIC RESINS, RUBBERS, PAINTS, OILS TO STABILIZE FROM PHOTOOXIDATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-04-09 US claimed
US-5384348-A Improved photostability for polymers, weather resistance SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-01-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312477-A1 INHIBITOR OF VAPOR SPACE POLYMERIZATION NOX4, VAT1, PNMT GAA 1542/4885L3MBTL1 3646/4885ALDH1A1 581/4885
US-20230312440-A1 ANTIFOULANT COMPOSITIONS FOR HIGH-SEVERITY PROCESSING OF VINYLIC MONOMER STREAMS MMAB, ALOX5, AS3MT GAA 3525/4885L3MBTL1 1952/4885ALDH1A1 161/4885
US-20230312441-A1 ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS DDT, PLD1, PNMT GAA 2248/4885L3MBTL1 3181/4885ALDH1A1 160/4885
US-20220119365-A1 CB1R RECEPTOR BLOCKERS WITH ACYCLIC BACKBONES CNR1, CNR2, HCRTR1 GAA 4067/4885L3MBTL1 3975/4885ALDH1A1 1579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.